animals with sterile CSF were excluded from the numbers in saline controls (group IV). The numbers of CFU per milliliter of these fluids were significantly lower than those in groups I and II (P < 0.001).
Blood and CSF levels of ampicillin (after 3.125 mg/kg per dose) and nafcillin (after 50 mg/kg per dose) are shown in Fig. 1 . The peak CSF level of ampicillin was 0.82 ± 0.1 ,ug/ml (range, 0.7 to 0.9 ,ug/ml), and the peak blood level was 15.2 + 3.4 ,ug/ml (range, 12.3 to 21.0 ,Ag/ml). Peak CSF concentrations were 5 to 7% of peak serum levels. The peak CSF level of nafcillin was 1.45 ± 0.53 ,ug/ml (range, 1.0 to 2.4 ,ug/ml), and the peak blood level was 55.30 ± 9.13 ,ug/ml (range, 43 to 67,tg/ml); peak CSF concentrations were approximately 2.5 to 3% those of serum levels.
DISCUSSION
The antibiotic dosages applied in the present study were chosen to simulate blood levels encountered in children treated with conventional dosages. Average peak ampicillin blood levels were reported to range from 6.4 to 38,ug/ml after a 30-to 35-mg/kg dose given intravenously every 6 h in children (8) . In comparison, the average peak blood level of infant rats in this study was 15.2 ,tg/ml (range, 12.3 to 21.0 ,tg/ml) after intraperitoneal injection of 3.125 mg/kg. The average reported peak blood level of nafcillin in children after intravenous administration of 37.5 mg/kg is 50 ,ug/ml (4) . Such a blood level was attained in infant rats, with administrations of 50 mg/kg every 6 h. At such blood levels, neither ampicillin nor nafcillin alone effected sterilization of blood or CSF in the rat model. Although peak ampicillin blood levels were equal to or exceeded the in vitro MIC of the ampicillinresistant H. influenzae type b, there was minimal reduction in the concentration of viable bacteria in the blood of treated animals in group I. In group II, despite nafcillin levels in the blood which were fourfold greater than the in vitro MIC for the organism, no inhibition was noticed. The reasons for these poor responses are unknown.
In contrast, the same doses of ampicillin and nafcillin in combination were very effective, leading to eradication of the bacteria from the blood in 18 of 19 infant rats within 30 h. In addition, despite CSF antibiotic levels which were well below the MICs of the organism for each antibiotic alone, the combination of drugs eradicated the bacteria in 15 of 19 animals and was associated with significant decrease in concentration of organisms in the remaining four animals.
Previous reports suggested that ampicillin in high dosage (100 mg/kg) was occasionally effective in sterilizing blood and CSF in infant rats with bacteremia and meningitis caused by ampicillin-resistant H. influenzae type b (6). When we used ampicillin alone in a dose of 12.5 mg/kg every 6 h (data not shown), we confirmed this observation. However, at a dosage which produces blood levels comparable to those achieved in humans (3.125 mg/kg every 6 h), ampicillin alone failed to eradicate the bacteria.
The present study provided evidence of in vitro synergism between ampicillin and nafcillin against a strain of H. influenzae which produced ,B-lactamase, as was shown previously by us (10) and by others (1) . The results in the infant rat model suggest that the combination of ampicillin and nafcillin is also synergistic in vivo.
Several authors recently recommended combination therapy with ampicillin and a penicillinase-resistant penicillin for childhood infections likely to be due to H. influenzae type b such as septic arthritis (5, 7) or acute orbital (9) and periorbital (2) cellulitis. The results of this study suggest that the combination of ampicillin and nafcillin may be effective therapy for such conditions even when the etiological agent is ampicillin-resistant H. influenzae. The value of such a regimen is that it eliminates the need for chloramphenicol which has potentially fatal side effects.
